Combination of the histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC cells and AML cells with activating mutation of FLT-3. (Q40498632)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combination of the histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC cells and AML cells with activating mutation of FLT-3. |
scientific article |
Statements
1 reference
Combination of the histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC cells and AML cells with activating mutation of FLT-3. (English)
1 reference
Prince George
1 reference
Purva Bali
1 reference
Srinivas Annavarapu
1 reference
Anna Scuto
1 reference
Warren Fiskus
1 reference
Fei Guo
1 reference
Celia Sigua
1 reference
Gautam Sondarva
1 reference
Lynn Moscinski
1 reference
Peter Atadja
1 reference
Kapil Bhalla
1 reference
28 October 2004
1 reference
1 reference
105
1 reference
4
1 reference
1768-1776
1 reference
Identifiers
1 reference
1 reference